These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 24381724)
41. Gut check on diabesity: leveraging gut mechanisms for the treatment of type 2 diabetes and obesity. Will S; Hornigold DC; Baker DJ; Coghlan MP; Mesquita M; Trevaskis JL; Naylor J Curr Opin Pharmacol; 2017 Dec; 37():10-15. PubMed ID: 28802873 [TBL] [Abstract][Full Text] [Related]
42. Gut and hormones and obesity. Wren AM Front Horm Res; 2008; 36():165-181. PubMed ID: 18230902 [TBL] [Abstract][Full Text] [Related]
43. Gastric bypass surgery restores meal stimulation of the anorexigenic gut hormones glucagon-like peptide-1 and peptide YY independently of caloric restriction. Evans S; Pamuklar Z; Rosko J; Mahaney P; Jiang N; Park C; Torquati A Surg Endosc; 2012 Apr; 26(4):1086-94. PubMed ID: 22044971 [TBL] [Abstract][Full Text] [Related]
44. The Effect of a Subcutaneous Infusion of GLP-1, OXM, and PYY on Energy Intake and Expenditure in Obese Volunteers. Tan T; Behary P; Tharakan G; Minnion J; Al-Najim W; Albrechtsen NJW; Holst JJ; Bloom SR J Clin Endocrinol Metab; 2017 Jul; 102(7):2364-2372. PubMed ID: 28379519 [TBL] [Abstract][Full Text] [Related]
45. Effect of Sleeve Gastrectomy on Ghrelin, GLP-1, PYY, and GIP Gut Hormones: A Systematic Review and Meta-analysis. McCarty TR; Jirapinyo P; Thompson CC Ann Surg; 2020 Jul; 272(1):72-80. PubMed ID: 31592891 [TBL] [Abstract][Full Text] [Related]
46. Do Gut Hormones Contribute to Weight Loss and Glycaemic Outcomes after Bariatric Surgery? Papamargaritis D; le Roux CW Nutrients; 2021 Feb; 13(3):. PubMed ID: 33652862 [TBL] [Abstract][Full Text] [Related]
47. Combined GLP-1, Oxyntomodulin, and Peptide YY Improves Body Weight and Glycemia in Obesity and Prediabetes/Type 2 Diabetes: A Randomized, Single-Blinded, Placebo-Controlled Study. Behary P; Tharakan G; Alexiadou K; Johnson N; Wewer Albrechtsen NJ; Kenkre J; Cuenco J; Hope D; Anyiam O; Choudhury S; Alessimii H; Poddar A; Minnion J; Doyle C; Frost G; Le Roux C; Purkayastha S; Moorthy K; Dhillo W; Holst JJ; Ahmed AR; Prevost AT; Bloom SR; Tan TM Diabetes Care; 2019 Aug; 42(8):1446-1453. PubMed ID: 31177183 [TBL] [Abstract][Full Text] [Related]
48. News in gut-brain communication: a role of peptide YY (PYY) in human obesity and following bariatric surgery? Hanusch-Enserer U; Roden M Eur J Clin Invest; 2005 Jul; 35(7):425-30. PubMed ID: 16008543 [TBL] [Abstract][Full Text] [Related]
49. The altered enteroendocrine reportoire following roux-en-Y-gastric bypass as an effector of weight loss and improved glycaemic control. Moffett RC; Docherty NG; le Roux CW Appetite; 2021 Jan; 156():104807. PubMed ID: 32871202 [TBL] [Abstract][Full Text] [Related]
51. Gut hormones and the control of appetite. Small CJ; Bloom SR Trends Endocrinol Metab; 2004 Aug; 15(6):259-63. PubMed ID: 15358278 [TBL] [Abstract][Full Text] [Related]
52. Peptide YY and glucagon-like peptide-1 in morbidly obese patients before and after surgically induced weight loss. Reinehr T; Roth CL; Schernthaner GH; Kopp HP; Kriwanek S; Schernthaner G Obes Surg; 2007 Dec; 17(12):1571-7. PubMed ID: 18046613 [TBL] [Abstract][Full Text] [Related]
53. Important Role of the GLP-1 Axis for Glucose Homeostasis after Bariatric Surgery. Larraufie P; Roberts GP; McGavigan AK; Kay RG; Li J; Leiter A; Melvin A; Biggs EK; Ravn P; Davy K; Hornigold DC; Yeo GSH; Hardwick RH; Reimann F; Gribble FM Cell Rep; 2019 Feb; 26(6):1399-1408.e6. PubMed ID: 30726726 [TBL] [Abstract][Full Text] [Related]
54. Differential effects of bile acids on the postprandial secretion of gut hormones: a randomized crossover study. McGlone ER; Malallah K; Cuenco J; Wewer Albrechtsen NJ; Holst JJ; Vincent RP; Ling C; Khan OA; Verma S; Ahmed AR; Walters JRF; Khoo B; Bloom SR; Tan TMM Am J Physiol Endocrinol Metab; 2021 Apr; 320(4):E671-E679. PubMed ID: 33459181 [TBL] [Abstract][Full Text] [Related]
55. Gut Hormones and Appetite Control: A Focus on PYY and GLP-1 as Therapeutic Targets in Obesity. De Silva A; Bloom SR Gut Liver; 2012 Jan; 6(1):10-20. PubMed ID: 22375166 [TBL] [Abstract][Full Text] [Related]
56. Mechanisms of disease: the role of gastrointestinal hormones in appetite and obesity. Vincent RP; Ashrafian H; le Roux CW Nat Clin Pract Gastroenterol Hepatol; 2008 May; 5(5):268-77. PubMed ID: 18382432 [TBL] [Abstract][Full Text] [Related]
57. Glucagon and other proglucagon-derived peptides in the pathogenesis of obesity. Holst JJ Front Nutr; 2022; 9():964406. PubMed ID: 35990325 [TBL] [Abstract][Full Text] [Related]